VivoSim Labs, Inc. Common Stock (VIVS) — Analysis Summary
VivoSim Labs, Inc. Common Stock (VIVS) has a market cap of $3.79M with year-over-year revenue growth of +32.1%. Net margin stands at -1727.8%. The stock trades at a P/E ratio of -1.5.
Key Takeaways
- Revenue changed +32.1% year-over-year
- Net margin of -1727.8%
- P/E ratio of -1.5
Compared to other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, VIVS posted revenue growth of +32.1% and trades at a P/E of -1.5.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.